Back to 
Baker Bros. Advisors LP
Baker Bros. Advisors LP
DNTH
5 quarters
Position history for Baker Bros. Advisors LP's holdings in Dianthus Therapeutics, Inc.
Yes. Baker Bros. Advisors holds 852,164 shares of DNTH (Dianthus Therapeutics), worth $83.1M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Baker Bros. Advisors has held DNTH since Q2 2025, across 5 quarterly 13F filings. DNTH is 0.4% of Baker Bros. Advisors' reported 13F portfolio.
Current Value
$83.1M
Current Shares
852,164
Total Value Change
+$68.4M
Total Shares Change
+62,405
Quarter-by-Quarter History